These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 9198238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.
    EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193
    [Abstract] [Full Text] [Related]

  • 3. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marmé D, Martiny-Baron G.
    Cancer Res; 1999 Jul 01; 59(13):3185-91. PubMed ID: 10397264
    [Abstract] [Full Text] [Related]

  • 4. Functions of the VEGF/VEGF receptor system in the vascular system.
    Breier G.
    Semin Thromb Hemost; 2000 Jul 01; 26(5):553-9. PubMed ID: 11129412
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S.
    Med Sci Monit; 2000 Jul 01; 6(5):1047-52. PubMed ID: 11208453
    [Abstract] [Full Text] [Related]

  • 6. VEGFs, receptors and angiogenesis.
    Veikkola T, Alitalo K.
    Semin Cancer Biol; 1999 Jun 01; 9(3):211-20. PubMed ID: 10343072
    [Abstract] [Full Text] [Related]

  • 7. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 1999 Nov 01; 30(5):1179-86. PubMed ID: 10534339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A.
    Nature; 1994 Feb 10; 367(6463):576-9. PubMed ID: 8107827
    [Abstract] [Full Text] [Related]

  • 12. VEGF receptor signal transduction.
    Matsumoto T, Claesson-Welsh L.
    Sci STKE; 2001 Dec 11; 2001(112):re21. PubMed ID: 11741095
    [Abstract] [Full Text] [Related]

  • 13. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K.
    Cancer Res; 2000 Jan 15; 60(2):203-12. PubMed ID: 10667560
    [No Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 15; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 15. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
    Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM.
    Cancer Res; 1996 Apr 01; 56(7):1615-20. PubMed ID: 8603410
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H, Ahmed A, Dantzer V.
    Placenta; 1999 Jan 01; 20(1):35-43. PubMed ID: 9950143
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Jan 01; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 18. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.
    Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR.
    Nat Med; 1999 Dec 01; 5(12):1390-5. PubMed ID: 10581081
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
    Kremer C, Breier G, Risau W, Plate KH.
    Cancer Res; 1997 Sep 01; 57(17):3852-9. PubMed ID: 9288799
    [Abstract] [Full Text] [Related]

  • 20. [Angiogenesis--vascular endothelial growth factor and its receptors].
    Shibuya M.
    Hum Cell; 1999 Mar 01; 12(1):17-24. PubMed ID: 10457901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.